Diphenylpyraline hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for diphenylpyraline hydrochloride and what is the scope of freedom to operate?
Diphenylpyraline hydrochloride
is the generic ingredient in one branded drug marketed by Glaxosmithkline and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for diphenylpyraline hydrochloride
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 74 |
Patent Applications: | 481 |
DailyMed Link: | diphenylpyraline hydrochloride at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for diphenylpyraline hydrochloride
US Patents and Regulatory Information for diphenylpyraline hydrochloride
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | HISPRIL | diphenylpyraline hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 011945-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |